Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.70 |
| ▸ | GAA | P10253 | 3/20 | 0.70 |
| ▸ | MAPT | P10636 | 3/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.70 |
| ▸ | POLB | P06746 | 2/20 | 0.70 |
| ▸ | HPGD | P15428 | 2/20 | 0.70 |
| ▸ | APEX1 | P27695 | 2/20 | 0.70 |
| ▸ | BLM | P54132 | 2/20 | 0.70 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.70 |
| ▸ | RGS12 | O14924 | 1/20 | 0.70 |
| ▸ | LMNA | P02545 | 1/20 | 0.70 |
| ▸ | TSHR | P16473 | 1/20 | 0.70 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.70 |
| ▸ | THPO | P40225 | 1/20 | 0.70 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.70 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1331519 | 1.00 | KDM4E (0.70) | KDM4EHSD17B10TDP1GAAMAPT | |
| Hydrochloric Acid SCHEMBL28072109 | 0.98 | KDM4E (0.68) | KDM4EHSD17B10TDP1GAAMAPT | |
| Hydrochloric Acid SCHEMBL28072108 | 0.96 | KDM4E (0.66) | KDM4EHSD17B10TDP1GAAMAPT | |
| Phenylpyruvate SCHEMBL28866614 | 0.93 | KDM4E (0.61) | KDM4EHSD17B10TDP1GAAMAPT | |
| Pyruvate SCHEMBL21494174 | 0.93 | KDM4E (0.61) | KDM4EHSD17B10TDP1GAAMAPT | |
| SCHEMBL6348938 | 0.85 | GAA (0.53) | KDM4EHSD17B10TDP1GAAMAPT | |
| SCHEMBL6348930 | 0.85 | KDM4E (0.53) | KDM4EHSD17B10TDP1GAAMAPT | |
| SCHEMBL6348933 | 0.84 | GAA (0.51) | KDM4EHSD17B10TDP1GAAMAPT | |
| SCHEMBL6348936 | 0.83 | KDM4E (0.50) | KDM4EHSD17B10TDP1GAAMAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL29382155 | 0.83 | GAA (1.00) | KDM4EHSD17B10TDP1GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120736724-B | Recovery treatment process of high-salt wastewater | Jiangsu Fengshan Biochemical Technology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| US-20250186382-A1 | PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION | ABBVIE INC. | 2025-06-12 | — | — | US | claimed |
| US-20250012780-A1 | Application of Organic Acids in Urine for Health Management | OU YUNG CHUN (TW) | 2025-01-09 | — | — | US | claimed |
| CN-115178220-B | Synthesis device and method for preparing cyhalofop-butyl | 甘肃联凯生物科技有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-115490617-B | Preparation process of cyhalofop-butyl with low cost and high optical purity content | 江苏丰山生化科技有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-115490617-A | Preparation process of low-cost high-light pure content cyhalofop-butyl | 江苏丰山集团股份有限公司 | 2022-12-20 | — | — | CN | claimed |
| CN-115178220-A | Synthesis device and method for preparation of cyhalofop-butyl | 甘肃联凯生物科技有限公司 | 2022-10-14 | — | — | CN | claimed |
| CN-113024739-B | Preparation method of catechol-based fluorescent micelle for iron ion detection | 南京理工大学 | 2022-03-22 | — | — | CN | claimed |
| CN-120736724-B | Recovery treatment process of high-salt wastewater | Jiangsu Fengshan Biochemical Technology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-122042984-A | Kit for screening people with high risk of liver injury caused by chemotherapeutic drug methotrexate and application of detection reagent in preparation of methotrexate liver injury prediction product | 中南大学湘雅二医院 | 2026-05-15 | — | — | CN | disclosed |
| US-20260014108-A1 | Levodopa and Carbidopa Intestinal Gel and Methods of Use | ABBVIE INC. (US) | 2026-01-15 | — | — | US | disclosed |
| US-20250325507-A1 | PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION | ABBVIE INC (US) | 2025-10-23 | — | — | US | disclosed |
| CN-120667898-A | Drying device for DHPPA | 安徽安和生物科技有限公司 | 2025-09-19 | — | — | CN | disclosed |
| CN-120667898-A | Drying device for DHPPA | 安徽安和生物科技有限公司 | 2025-09-19 | — | — | CN | disclosed |
| US-11413262-B2 | Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof | INTRANCE INTERNATIONAL AB (SE) | 2022-08-16 | — | — | US | disclosed |
| US-20220233610-A1 | MODULATION OF MICROBIOTA FUNCTION BY GENE THERAPY OF THE MICROBIOME TO PREVENT, TREAT OR CURE MICROBIOME-ASSOCIATED DISEASES OR DISORDERS | ELIGO BIOSCIENCE (FR) | 2022-07-28 | — | — | US | disclosed |
| CN-109880862-B | Method for heterologous de novo biosynthesis of salvianolic acid B | 上海中医药大学 | 2022-07-26 | — | — | CN | disclosed |
| US-11376286-B2 | Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders | ELIGO BIOSCIENCE (FR) | 2022-07-05 | — | — | US | disclosed |
| CN-113024739-B | Preparation method of catechol-based fluorescent micelle for iron ion detection | 南京理工大学 | 2022-03-22 | — | — | CN | disclosed |
| CN-113024739-B | Preparation method of catechol-based fluorescent micelle for iron ion detection | 南京理工大学 | 2022-03-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325507-A1 | PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION | PARK7, PYGB, SNCA | KDM4E 2932/4885HSD17B10 1607/4885TDP1 342/4885 |
| US-11413262-B2 | Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof | COMT, DDT, DDC | KDM4E 2546/4885HSD17B10 424/4885TDP1 444/4885 |
| US-20250186382-A1 | PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION | PARK7, PYGB, SNCA | KDM4E 2932/4885HSD17B10 1607/4885TDP1 342/4885 |
| US-20260014108-A1 | Levodopa and Carbidopa Intestinal Gel and Methods of Use | PARK7, SNCA, COMT | KDM4E 2556/4885HSD17B10 3050/4885TDP1 395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.